Northern Trust’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.26B Sell
27,090,023
-144,619
-0.5% -$16.7M 0.43% 32
2025
Q4
$2.87B Sell
27,234,642
-698,499
-3% -$65.6M 0.37% 40
2025
Q3
$2.34B Sell
27,933,141
-812,286
-3% -$66.9M 0.3% 50
2025
Q2
$2.28B Sell
28,745,427
-1,645,437
-5% -$131M 0.31% 48
2025
Q1
$2.73B Sell
30,390,864
-986,243
-3% -$92.1M 0.41% 36
2024
Q4
$3.12B Buy
31,377,107
+4,511,742
+17% +$465M 0.44% 29
2024
Q3
$3.05B Buy
26,865,365
+45,089
+0.2% +$5.36M 0.5% 27
2024
Q2
$3.32B Sell
26,820,276
-279,350
-1% -$36M 0.56% 24
2024
Q1
$3.58B Sell
27,099,626
-1,392,018
-5% -$172M 0.62% 23
2023
Q4
$3.11B Sell
28,491,644
-1,367,979
-5% -$142M 0.56% 26
2023
Q3
$3.07B Buy
29,859,623
+1,186,842
+4% +$128M 0.6% 24
2023
Q2
$3.31B Sell
28,672,781
-1,812,290
-6% -$206M 0.64% 23
2023
Q1
$3.24B Buy
30,485,071
+271,188
+0.9% +$29.3M 0.64% 23
2022
Q4
$3.35B Buy
30,213,883
+323,762
+1% +$33.1M 0.7% 22
2022
Q3
$2.57B Sell
29,890,121
-59,566
-0.2% -$5.32M 0.59% 25
2022
Q2
$2.73B Buy
29,949,687
+214,082
+0.7% +$19M 0.58% 26
2022
Q1
$2.44B Sell
29,735,605
-276,664
-0.9% -$21.8M 0.43% 37
2021
Q4
$2.3B Sell
30,012,269
-1,015,659
-3% -$80.9M 0.38% 48
2021
Q3
$2.33B Sell
31,027,928
-233,505
-0.7% -$17.8M 0.41% 47
2021
Q2
$2.43B Sell
31,261,433
-2,365,002
-7% -$176M 0.43% 39
2021
Q1
$2.47B Sell
33,626,435
-822,541
-2% -$60.7M 0.46% 38
2020
Q4
$2.69B Sell
34,448,976
-910,943
-3% -$69.7M 0.52% 26
2020
Q3
$2.8B Sell
35,359,919
-21,299
-0.1% -$1.67M 0.61% 24
2020
Q2
$2.61B Buy
35,381,218
+901,474
+3% +$67.9M 0.62% 22
2020
Q1
$2.53B Buy
34,479,744
+833,035
+2% +$65.5M 0.73% 19
2019
Q4
$2.92B Sell
33,646,709
-544,993
-2% -$44.8M 0.65% 24
2019
Q3
$2.75B Sell
34,191,702
-22,865
-0.1% -$1.83M 0.66% 25
2019
Q2
$2.74B Sell
34,214,567
-168,201
-0.5% -$12.9M 0.65% 26
2019
Q1
$2.73B Buy
34,382,768
+325,117
+1% +$24.3M 0.67% 24
2018
Q4
$2.48B Buy
34,057,651
+997,602
+3% +$70.4M 0.7% 23
2018
Q3
$2.24B Sell
33,060,049
-1,115,397
-3% -$71.1M 0.55% 30
2018
Q2
$1.98B Sell
34,175,446
-742,607
-2% -$41.9M 0.5% 32
2018
Q1
$1.81B Sell
34,918,053
-2,397,400
-6% -$129M 0.47% 36
2017
Q4
$2B Sell
37,315,453
-1,389,880
-4% -$77.1M 0.51% 36
2017
Q3
$2.36B Buy
38,705,333
+1,733,448
+5% +$105M 0.62% 27
2017
Q2
$2.26B Sell
36,971,885
-625,239
-2% -$38.1M 0.63% 25
2017
Q1
$2.28B Buy
37,597,124
+301,439
+0.8% +$18.3M 0.66% 23
2016
Q4
$2.1B Sell
37,295,685
-680,777
-2% -$39.8M 0.64% 24
2016
Q3
$2.26B Buy
37,976,462
+431,661
+1% +$25.2M 0.7% 21
2016
Q2
$2.06B Sell
37,544,801
-302,412
-0.8% -$16.1M 0.67% 22
2016
Q1
$1.91B Sell
37,847,213
-1,333,654
-3% -$65.3M 0.63% 24
2015
Q4
$1.97B Sell
39,180,867
-2,396,830
-6% -$121M 0.65% 24
2015
Q3
$1.96B Sell
41,577,697
-1,314,467
-3% -$69.8M 0.65% 24
2015
Q2
$2.33B Sell
42,892,164
-73,553
-0.2% -$4.13M 0.7% 18
2015
Q1
$2.36B Sell
42,965,717
-1,413,451
-3% -$80M 0.71% 16
2014
Q4
$2.4B Sell
44,379,168
-533,452
-1% -$29.7M 0.73% 16
2014
Q3
$2.54B Sell
44,912,620
-1,001,008
-2% -$56.2M 0.8% 18
2014
Q2
$2.53B Buy
45,913,628
+85,055
+0.2% +$4.64M 0.79% 18
2014
Q1
$2.48B Sell
45,828,573
-360,714
-0.8% -$18.7M 0.78% 18
2013
Q4
$2.21B Buy
46,189,287
+185,484
+0.4% +$8.48M 0.71% 18
2013
Q3
$2.09B Sell
46,003,803
-2,540,117
-5% -$116M 0.74% 18
2013
Q2
$2.15B Buy
+48,543,920
New +$2.17B 0.78% 19

Other funds holding MRK

Northern Trust's MRK Position: Q1 2026 in Review

Northern Trust reduced its Merck (MRK) stake by 0.53% in Q1 2026, selling an estimated $16.7M and leaving 27,090,023 shares worth $3.26B. The position accounts for 0.43% of the portfolio, ranked #32.

Northern Trust first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.58B in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Northern Trust held 27,090,023 shares of Merck worth $3.26B as of Q1 2026.
  • Northern Trust sold 144,619 Merck shares in Q1 2026, an estimated $16.7M.
  • Merck made up 0.43% of Northern Trust's portfolio in Q1 2026, its #32 holding.
  • Northern Trust first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Northern Trust's Merck position peaked at $3.58B in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.